Abmaxis, Inc.
Records under this name other than patents Abmaxis, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 8 of 8 · Back to Abmaxis, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,462,698 | Anti-CD26 antibodies and methods of use thereof Formerly held Term ended Term ended Jul 24, 2026 · From the USPTO record | Term ended | Term ended Jul 24, 2026 | From the USPTO record |
| US 7,910,350 | Adaptor-directed helper systems Lapsed on the fee record Ended Mar 22, 2023 · From the USPTO record | Lapsed on the fee record | Ended Mar 22, 2023 | From the USPTO record |
| US 7,179,595 | Compositions and methods for generating antigen-binding units Formerly held Term ended Term ended Aug 22, 2022 · From the USPTO record | Term ended | Term ended Aug 22, 2022 | From the USPTO record |
| US 7,175,983 | Adapter-directed display systems Term ended Term ended Aug 9, 2022 · From the USPTO record | Term ended | Term ended Aug 9, 2022 | From the USPTO record |
| US 7,429,652 | Compositions and methods for generating chimeric heteromultimers Term ended Term ended Jan 6, 2022 · From the USPTO record | Term ended | Term ended Jan 6, 2022 | From the USPTO record |
| US 6,833,441 | Compositions and methods for generating chimeric heteromultimers Term ended Term ended Nov 10, 2021 · From the USPTO record | Term ended | Term ended Nov 10, 2021 | From the USPTO record |
| US 7,117,096 | Structure-based selection and affinity maturation of antibody library Lapsed on the fee record Ended Oct 3, 2014 · From the USPTO record | Lapsed on the fee record | Ended Oct 3, 2014 | From the USPTO record |
| US 7,667,004 | Humanized antibodies against vascular endothelial growth factor Lapsed on the fee record Ended Feb 23, 2014 · From the USPTO record | Lapsed on the fee record | Ended Feb 23, 2014 | From the USPTO record |